NMPA

Random entry RSS

Posted in:
Regulatory

2019 Ends and 2020 Begins with a Flurry of Biosimilar Activity in East Asian Markets
By Spencer Johnson February 24, 2020 Comments are off
A white paper released in 2019 by The Biosimilars Forum and Medicines for Europe shows the United States and Europe accounting for more...

Read more

Tagged with: AbbVie, adalimumab, East Asia, Featured, Humira®, NMPA, Rituxan®, Rituximab

http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
ShareEmail, Linked In, Twitter, Facebook, Google Plus

Back to Top